Plasma and synovial fluid concentrations of calcium pentosan polysulphate achieved in the horse following intramuscular injection.

This research explored the role of calcium pentosan polysulphate (CaPPS) in treating osteoarthritis in horses. The study determined the concentration of CaPPS in the synovial fluid and plasma post an intramuscular injection, providing foundational data for potential therapeutic application.

Understanding the potential of CaPPS in treating equine osteoarthritis

• Initial in vitro studies have indicated that CaPPS could have potential therapeutic benefits for the treatment of osteoarthritis (OA) in horses. However, the lack of controlled clinical trials using CaPPS in cases of equine OA necessitated an examination.
• This research aims to understand the relationship of the dosage of CaPPS on the drug’s concentration in the plasma and synovial fluid of the target joint, which may aid in defining the optimal dosage for practical therapeutic use.

The Course of the Study

• The researchers injected a single 2mg/kg dose of CaPPS intramuscularly into six healthy horses. They will subsequently sample blood and synovial fluid from the subjects.
• The objective was to analyze the concentrations of CaPPS present in the synovial fluid and plasma following the injection. This information will help to assess the bioavailability of CaPPS within critical areas such as the synovial joint, which is often affected by OA.

Results and Future Implications

• The controlled study revealed that the presence of CaPPS in the synovial fluid post injection was sufficient to potentially influence synoviocyte metabolism, which is instrumental in the maintenance of joint health.
• The concentrations might also stimulate proteoglycan synthesis and inhibit matrix metalloproteinase activities – the latter is an enzyme system that breaks down cartilage in OA. Hence, this suggests that CaPPS could play a role in preserving articular cartilage in horses suffering from OA.
• Given the relatively successful outcomes of this investigation, the study concludes by advocating further research into the therapeutic effect of CaPPS on equine OA to substantiate these preliminary findings.